Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-068409
Filing Date
2025-07-16
Accepted
2025-07-16 18:02:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 16723
2 EXHIBIT 99.1 tm2521087d1_ex99-1.htm EX-99.1 10869
  Complete submission text file 0001104659-25-068409.txt   29216
Mailing Address 830 BRICKELL PLAZA MIAMI FL 33131
Business Address 830 BRICKELL PLAZA MIAMI FL 33131 305-929-6851
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Subject) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90685 | Film No.: 251128313
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)